SHMT2 and neoplasm: Furthermore, SHMT2 expression is significantly related with tumor T stage (P = 0.017) and tumor TNM stage (P = 0.041) in patients with iCCA, disregarding age, gender, tumor size, tumor number, pathological grade, vascular invasion, or lymph node metastasis.